Developer docs
API playgroundTry for free, no card

Search company profiles

Iterative Scopes

Full company profile

uuid0000aey

Namestring
Iterative Scopes
Legal namestring
Iterative Health
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Iterative Health, formerly known as Iterative Scopes, is a Cambridge, Massachusetts-based clinical research site network founded in 2017 that connects pharmaceutical sponsors and contract research organizations (CROs) with community-based healthcare providers running clinical trials. The company organizes its operations around four therapeutic focus areas: gastroenterology (GI), hepatology, obesity, and, following its May 2026 acquisition of NextStage Clinical Research's cardiology sites, cardiology. Iterative Health monetizes through professional services agreements in which it provides site activation, patient enrollment, and trial execution support to sponsors and CROs, while simultaneously enabling provider partners (such as GI Alliance, One GI, and US Heart & Vascular) to operate clinical research as a revenue line within their practices.

Short descriptiontext

Iterative Health is a clinical trial site network connecting pharmaceutical sponsors and CROs with community-based GI, hepatology, obesity, and cardiology providers, using its SKOUT® AI tool to accelerate patient enrollment and site operations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, site network management, AI patient enrollment, GI clinical research, sponsor partnership solutions
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Site Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Trial Site Services
TypeProfessional Services
Description

Revenue generated from providing clinical trial site network services to pharmaceutical sponsors and CROs, including patient enrollment, site activation, and trial execution support for GI, Hepatology, Obesity, and Cardiology therapeutic areas.

iterative.health
2Patient Enrollment Services
TypeProfessional Services
Description

Master services agreements with clinical trial sponsors to assist with patient enrollment for Phase 2 clinical trials, as evidenced by the Palisade Bio agreement.

in.investing.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1SKOUT®
Description

AI-powered tool referenced on the Iterative Health website under products section, aimed at helping sites and sponsors accelerate clinical trial operations.

iterative.health
Core offering1 text field

Iterative Health (formerly Iterative Scopes) operates a global, performance-driven clinical trial site network embedded in community-based healthcare practices for GI, Hepatology, Obesity, and Cardiology therapeutic areas. The company provides pharmaceutical sponsors and CROs with site selection, site activation, patient enrollment, and trial execution services, while offering participating providers access to research studies, operational support, and AI-powered enrollment technology (SKOUT®).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Double the patient enrollment rate compared to industry benchmarks
+2 more records
Product overview1 text field

Iterative Health operates as a clinical research site network that connects sponsors and CROs with community-based healthcare providers. The company offers the SKOUT® product along with a global Site Network of research sites. They serve providers (helping them grow research ancillary with access to studies, operational support, and AI technology) and sponsors/CROs (providing site selection, activation speed, and patient enrollment). The company focuses on GI, Hepatology, Obesity, and Cardiology therapeutic areas.

Product and service2 records
1SKOUT®
CategoryAI Clinical Trial Technology
Description

SKOUT® is an AI-powered technology tool that helps clinical trial sites and sponsors accelerate patient enrollment and site operations with accuracy and precision.

2Iterative Health Site Network
CategoryClinical Trial Site Network
Description

A global network of clinical trial research sites embedded in community care settings, connecting pharmaceutical sponsors and CROs with high-performing sites for GI, Hepatology, Obesity, and Cardiology trials, while providing participating providers with research ancillary growth opportunities.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-02
Description

Master services agreement with Palisade Bio to assist with patient enrollment for a Phase 2 clinical trial, supporting Palisade Bio's clinical development program.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Strategic partnership with GI Alliance, the leading gastroenterology practice management organization, to expand access to clinical trials across community-based GI practices and accelerate advancement of new therapies for patients.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Partnership with One GI to expand access to clinical trials across their network of GI practices, enabling patients in community settings to participate in clinical research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Partnership with US Heart & Vascular to expand clinical trial access in the cardiology therapeutic area across their network of cardiovascular practices.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Operates a 'Goes Direct' community-based clinical research site network that brings trials into physician practices, directly mirroring Iterative Health's embedded-in-community-care model. Comparable in serving sponsors/CROs with community-site infrastructure and tech-enabled enrollment.

TypeDirect peer
Description

Runs a network of community-based clinical trial sites and offers tech-enabled patient enrollment and trial operations services. Directly comparable as a mid-stage site network competitor with similar provider-embedded strategy.

TypeBroad incumbent
Description

Large clinical trial solutions provider offering IRB, technology, and site-support services used by sponsors and CROs. Overlaps with Iterative Health on site enablement, technology tools, and sponsor-facing clinical trial services, but at broader portfolio scale.

TypeBroad incumbent
Description

World's largest CRO with extensive site network, clinical technology, and real-world evidence capabilities. Competes with Iterative Health for sponsor contracts and could expand community-site capacity internally to match the model.

TypeBroad incumbent
Description

Global CRO providing site management, patient recruitment, and clinical operations across therapeutic areas. Comparable in offering sponsors full-service trial delivery including site-facing services.

TypeBroad incumbent
Description

Post-spin CRO from Labcorp offering clinical trial site services, central lab, and patient recruitment. Overlaps with Iterative Health on sponsor-facing site management and patient enrollment services.

TypeBroad incumbent
Description

Mid-cap CRO with strong site management and patient recruitment operations, particularly competitive in specialty therapeutic areas including gastroenterology and cardiology where Iterative Health focuses.

TypeBroad incumbent
Description

Biopharmaceutical services organization offering clinical development and site management solutions. Competes for sponsor trial placement and patient enrollment mandates across therapeutic areas.

TypeEmerging player
Description

Pioneer in decentralized clinical trial (DCT) technology and site-less trial operations. Adjacent threat: represents the alternative operating model that may reduce reliance on physical site networks like Iterative Health's.

TypeEmerging player
Description

DCT platform providing virtual and hybrid trial execution for sponsors. Represents the structural shift toward decentralized models that could pressure community-site network economics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds17 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors21 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Iterative Scopes

Clinical Trial Site Servicesiterativescopes.com

Iterative Health is a clinical trial site network connecting pharmaceutical sponsors and CROs with community-based GI, hepatology, obesity, and cardiology providers, using its SKOUT® AI tool to accelerate patient enrollment and site operations.

What Iterative Scopes does

Iterative Health, formerly known as Iterative Scopes, is a Cambridge, Massachusetts-based clinical research site network founded in 2017 that connects pharmaceutical sponsors and contract research organizations (CROs) with community-based healthcare providers running clinical trials. The company organizes its operations around four therapeutic focus areas: gastroenterology (GI), hepatology, obesity, and, following its May 2026 acquisition of NextStage Clinical Research's cardiology sites, cardiology. Iterative Health monetizes through professional services agreements in which it provides site activation, patient enrollment, and trial execution support to sponsors and CROs, while simultaneously enabling provider partners (such as GI Alliance, One GI, and US Heart & Vascular) to operate clinical research as a revenue line within their practices.

Iterative Scopes firmographics

Firmographics
Name
Iterative Scopes
Legal name
Iterative Health
Website
https://iterativescopes.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Iterative Health is a clinical trial site network connecting pharmaceutical sponsors and CROs with community-based GI, hepatology, obesity, and cardiology providers, using its SKOUT® AI tool to accelerate patient enrollment and site operations.
Ownership category
akta.pro rank

Iterative Scopes industry classification

Industry
Product category
Clinical Trial Site Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLACAOAJ
Site & Investigator Platforms (Site Payments, Feasibility, Activation)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)

Keywords

  • Clinical trial services
  • Site network management
  • AI patient enrollment
  • GI clinical research
  • Sponsor partnership solutions

Where Iterative Scopes is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Iterative Scopes business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Trial Site Services: Revenue generated from providing clinical trial site network services to pharmaceutical sponsors and CROs, including patient enrollment, site activation, and trial execution support for GI, Hepatology, Obesity, and Cardiology therapeutic areas.
  2. Patient Enrollment Services: Master services agreements with clinical trial sponsors to assist with patient enrollment for Phase 2 clinical trials, as evidenced by the Palisade Bio agreement.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Iterative Scopes product offering

Product offering

Core offering

Iterative Health (formerly Iterative Scopes) operates a global, performance-driven clinical trial site network embedded in community-based healthcare practices for GI, Hepatology, Obesity, and Cardiology therapeutic areas. The company provides pharmaceutical sponsors and CROs with site selection, site activation, patient enrollment, and trial execution services, while offering participating providers access to research studies, operational support, and AI-powered enrollment technology (SKOUT®).

Product overview

Iterative Health operates as a clinical research site network that connects sponsors and CROs with community-based healthcare providers. The company offers the SKOUT® product along with a global Site Network of research sites. They serve providers (helping them grow research ancillary with access to studies, operational support, and AI technology) and sponsors/CROs (providing site selection, activation speed, and patient enrollment). The company focuses on GI, Hepatology, Obesity, and Cardiology therapeutic areas.

Differentiator

Problem solved

Functional benefit

Brands

  • SKOUT®: AI-powered tool referenced on the Iterative Health website under products section, aimed at helping sites and sponsors accelerate clinical trial operations.

Products and services

  • SKOUT® SKOUT® is an AI-powered technology tool that helps clinical trial sites and sponsors accelerate patient enrollment and site operations with accuracy and precision.
  • Iterative Health Site Network A global network of clinical trial research sites embedded in community care settings, connecting pharmaceutical sponsors and CROs with high-performing sites for GI, Hepatology, Obesity, and Cardiology trials, while providing participating providers with research ancillary growth opportunities.

Quantifiable outcome

  • Double the patient enrollment rate compared to industry benchmarks
  • +2 more outcomes

Companies that use Iterative Scopes

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Iterative Scopes technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Iterative Scopes partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor and core.

  • Palisade BiominorStrategic or Co-development Partner · 2 April 2026Master services agreement with Palisade Bio to assist with patient enrollment for a Phase 2 clinical trial, supporting Palisade Bio's clinical development program.
  • GI AlliancecoreStrategic or Co-development Partner · 1 January 2026Strategic partnership with GI Alliance, the leading gastroenterology practice management organization, to expand access to clinical trials across community-based GI practices and accelerate advancement of new therapies for patients.
  • One GIcoreStrategic or Co-development Partner · 1 January 2026Partnership with One GI to expand access to clinical trials across their network of GI practices, enabling patients in community settings to participate in clinical research.
  • US Heart & Vascular (USHV)coreStrategic or Co-development Partner · 1 January 2026Partnership with US Heart & Vascular to expand clinical trial access in the cardiology therapeutic area across their network of cardiovascular practices.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Iterative Scopes competitors and assessment

Company assessment

Direct peers

  • Elligo Health Research: Operates a 'Goes Direct' community-based clinical research site network that brings trials into physician practices, directly mirroring Iterative Health's embedded-in-community-care model. Comparable in serving sponsors/CROs with community-site infrastructure and tech-enabled enrollment.
  • Circuit Clinical: Runs a network of community-based clinical trial sites and offers tech-enabled patient enrollment and trial operations services. Directly comparable as a mid-stage site network competitor with similar provider-embedded strategy.

Broad incumbents

  • WCG (WIRB-Copernicus Group): Large clinical trial solutions provider offering IRB, technology, and site-support services used by sponsors and CROs. Overlaps with Iterative Health on site enablement, technology tools, and sponsor-facing clinical trial services, but at broader portfolio scale.
  • IQVIA: World's largest CRO with extensive site network, clinical technology, and real-world evidence capabilities. Competes with Iterative Health for sponsor contracts and could expand community-site capacity internally to match the model.
  • ICON plc: Global CRO providing site management, patient recruitment, and clinical operations across therapeutic areas. Comparable in offering sponsors full-service trial delivery including site-facing services.
  • Labcorp Drug Development (Fortrea): Post-spin CRO from Labcorp offering clinical trial site services, central lab, and patient recruitment. Overlaps with Iterative Health on sponsor-facing site management and patient enrollment services.
  • Medpace Holdings: Mid-cap CRO with strong site management and patient recruitment operations, particularly competitive in specialty therapeutic areas including gastroenterology and cardiology where Iterative Health focuses.
  • Syneos Health: Biopharmaceutical services organization offering clinical development and site management solutions. Competes for sponsor trial placement and patient enrollment mandates across therapeutic areas.

Emerging players

  • Science 37: Pioneer in decentralized clinical trial (DCT) technology and site-less trial operations. Adjacent threat: represents the alternative operating model that may reduce reliance on physical site networks like Iterative Health's.
  • ObvioHealth: DCT platform providing virtual and hybrid trial execution for sponsors. Represents the structural shift toward decentralized models that could pressure community-site network economics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Iterative Scopes social profiles

Digital presence

Iterative Scopes financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Iterative Scopes leadership team

Management profile

Number of profiles

Iterative Scopes subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Iterative Scopes funding detail

Funding detail

Funding overview

Funding rounds17 records

Investors21 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Iterative Scopes M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Iterative Scopes

What does Iterative Scopes do?

Iterative Health (formerly Iterative Scopes) operates a global, performance-driven clinical trial site network embedded in community-based healthcare practices for GI, Hepatology, Obesity, and Cardiology therapeutic areas. The company provides pharmaceutical sponsors and CROs with site selection, site activation, patient enrollment, and trial execution services, while offering participating providers access to research studies, operational support, and AI-powered enrollment technology (SKOUT®).

Is Iterative Scopes a public or private company?

Iterative Scopes is a private company. It is classified as venture growth investor backed and is currently operating.

When was Iterative Scopes founded?

Iterative Scopes was founded in 2017. It employs 101 to 250 people.

Where is Iterative Scopes based?

Iterative Scopes is headquartered in Cambridge, United States, in the North America region.

How does Iterative Scopes make money?

Two revenue lines are on record. Clinical Trial Site Services are the primary driver. The others are patient Enrollment Services.

Who are Iterative Scopes's main competitors?

Direct peers on record are Elligo Health Research and Circuit Clinical. Broad incumbents are WCG (WIRB-Copernicus Group), IQVIA, ICON plc, Labcorp Drug Development (Fortrea), Medpace Holdings and Syneos Health. Emerging players are Science 37 and ObvioHealth.

Does Iterative Scopes have an API?

No public API is recorded for Iterative Scopes.

What industry is Iterative Scopes in?

Iterative Scopes's product category is Clinical Trial Site Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogIterative Health Appoints Dr. Samin K. Sharma at Mount Sinai Hospital as Honorary Chair of Interventional CardiologyIterative Health appointed Dr. Samin K. Sharma, director of cardiovascular clinical research at Mount Sinai, as honorary chair of interventional cardiology. The appointment follows the company's US site network expansion, including acquisitions and partnerships, and aims to strengthen its cardiology research strategy.ContractpharmaIterative Health Acquires Three Texas Cardiology Sites from NextStage Clinical ResearchIterative Health acquired three cardiology sites in Texas—Beaumont, Port Arthur, and Waco—from NextStage Clinical Research. The acquisition expands Iterative's cardiology footprint and adds experienced researchers and community connections. The sites have active cardiology trial portfolios and established patient communities.Pulse 2.0Iterative Health: $77 Million Raised To Scale Multispecialty Clinical Research Network Powered By AIIterative Health closed a $77 million Series C round led by Intrepid Growth Partners and GV, with participation from EDBI and others. The company's multispecialty clinical research network includes over 100 sites and delivers 2x faster site activation and 3x higher enrollment rates. Funding will support expansion into cardiology and obesity and geographic growth.FinSMEsIterative Health Raises $77M in Series C FundingIterative Health raised $77M in Series C financing led by Intrepid Growth Partners and GV, with new investors EDBI and a family office. The funds will support operations and development, and the company plans to expand its global network of over 100 research sites.Business Wire BlogIterative Health and US Heart & Vascular Enter Strategic Partnership to Advance Community-Based Cardiovascular ResearchIterative Health and US Heart & Vascular announced a strategic partnership to advance community-based cardiovascular research. USHV research sites will join Iterative Health's global site network, which spans over 100 sites across three continents. The collaboration expands Iterative Health's multispecialty focus into cardiology.ContractpharmaIterative Health Adds Nadege Gunn as CMO, Hepatology and ObesityIterative Health hired Nadege Gunn as Chief Medical Officer for hepatology and obesity, and promoted Dana Feuchtbaum to chief operating officer. Gunn will lead strategic medical and scientific leadership and oversee site operations for the expanding portfolio. The move aims to accelerate novel therapies to market.YahooGI Alliance and Iterative Health Partner to Advance GI Clinical Research in the CommunityGI Alliance and Iterative Health announced a partnership to expand GI clinical trials across community practices. The collaboration adds 21 GIA research sites, bringing the network to over 70 locations in the US and Europe. Iterative Health will lead trial management, aiming to accelerate new therapies for GI and hepatology patients.InvestmentreportsJonathan Ng, Iterative HealthJonathan Ng founded Iterative Health to use AI for precision medicine and clinical trial efficiency. His SKOUT tool increased adenoma detection by 27% in a trial of 1,300 patients, and the company reports 2x faster site activation. He plans to expand its GI research site network into the hundreds.TatlerasiaJonathan NgJonathan Ng is founder and CEO of Iterative Health, which uses AI to improve gastrointestinal diagnosis by creating complex endoscopic videos. The company has raised over $195 million from healthcare players including Johnson & Johnson and Eli Lilly, and VCs including Insight Partners, Breyer Capital, and Alumni Ventures.Business Wire BlogIterative Health Announces Upcoming U.S. Availability of SKOUT®: Real-Time AI for Polyp DetectionIterative Health and Provation announced SKOUT, real-time AI for polyp detection, will be commercially available in the U.S. in the second quarter of 2023. The device, FDA-cleared and evaluated in a U.S. study, showed a 27% relative increase in adenoma detection per colonoscopy in a randomized trial. It integrates into existing workflows without affecting procedure time.